Michael Kennedy

Michael Kennedy has over six years of work experience in the clinical trial management field. Michael is currently the Director of Clinical Trial Management at DICE Therapeutics, a subsidiary of Eli Lilly and Company, since January 2024. Prior to this, they held positions as an Associate Director and Senior Clinical Trial Manager at the same company. Before joining DICE Therapeutics, Michael worked as a Clinical Trial Manager at Nektar Therapeutics from July 2020 to September 2021. Michael also gained experience at Genentech, where they served as a Global Clinical Trial Leader, Associate Global Clinical Trial Leader, Clinical Trial Associate, Resourcing Project Analyst, and Clinical Operations Intern. Additionally, they worked as an Outside Consultation Coordinator and Research Assistant at The Stone Clinic from January 2015 to May 2016.

Michael Kennedy attended Saint Ignatius College Preparatory for high school. Afterward, they went on to UC Irvine, where they obtained a Bachelor's Degree in Biological Sciences.